Xenon Pharmaceuticals Inc
F:XP0
Xenon Pharmaceuticals Inc?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
25
42.4
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does Xenon Pharmaceuticals Inc hold over its rivals?
What risks and challenges
does Xenon Pharmaceuticals Inc face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Xenon Pharmaceuticals Inc.
Provide an overview of the primary business activities
of Xenon Pharmaceuticals Inc.
What unique competitive advantages
does Xenon Pharmaceuticals Inc hold over its rivals?
What risks and challenges
does Xenon Pharmaceuticals Inc face in the near future?
Has there been any significant insider trading activity
in Xenon Pharmaceuticals Inc recently?
Summarize the latest earnings call
of Xenon Pharmaceuticals Inc.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Xenon Pharmaceuticals Inc.
Provide P/S
for Xenon Pharmaceuticals Inc.
Provide P/E
for Xenon Pharmaceuticals Inc.
Provide P/OCF
for Xenon Pharmaceuticals Inc.
Provide P/FCFE
for Xenon Pharmaceuticals Inc.
Provide P/B
for Xenon Pharmaceuticals Inc.
Provide EV/S
for Xenon Pharmaceuticals Inc.
Provide EV/GP
for Xenon Pharmaceuticals Inc.
Provide EV/EBITDA
for Xenon Pharmaceuticals Inc.
Provide EV/EBIT
for Xenon Pharmaceuticals Inc.
Provide EV/OCF
for Xenon Pharmaceuticals Inc.
Provide EV/FCFF
for Xenon Pharmaceuticals Inc.
Provide EV/IC
for Xenon Pharmaceuticals Inc.
Show me price targets
for Xenon Pharmaceuticals Inc made by professional analysts.
What are the Revenue projections
for Xenon Pharmaceuticals Inc?
How accurate were the past Revenue estimates
for Xenon Pharmaceuticals Inc?
What are the Net Income projections
for Xenon Pharmaceuticals Inc?
How accurate were the past Net Income estimates
for Xenon Pharmaceuticals Inc?
What are the EPS projections
for Xenon Pharmaceuticals Inc?
How accurate were the past EPS estimates
for Xenon Pharmaceuticals Inc?
What are the EBIT projections
for Xenon Pharmaceuticals Inc?
How accurate were the past EBIT estimates
for Xenon Pharmaceuticals Inc?
Compare the revenue forecasts
for Xenon Pharmaceuticals Inc with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Xenon Pharmaceuticals Inc and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Xenon Pharmaceuticals Inc against its competitors.
Analyze the profit margins
(gross, operating, and net) of Xenon Pharmaceuticals Inc compared to its peers.
Compare the P/E ratios
of Xenon Pharmaceuticals Inc against its peers.
Discuss the investment returns and shareholder value creation
comparing Xenon Pharmaceuticals Inc with its peers.
Analyze the financial leverage
of Xenon Pharmaceuticals Inc compared to its main competitors.
Show all profitability ratios
for Xenon Pharmaceuticals Inc.
Provide ROE
for Xenon Pharmaceuticals Inc.
Provide ROA
for Xenon Pharmaceuticals Inc.
Provide ROIC
for Xenon Pharmaceuticals Inc.
Provide ROCE
for Xenon Pharmaceuticals Inc.
Provide Gross Margin
for Xenon Pharmaceuticals Inc.
Provide Operating Margin
for Xenon Pharmaceuticals Inc.
Provide Net Margin
for Xenon Pharmaceuticals Inc.
Provide FCF Margin
for Xenon Pharmaceuticals Inc.
Show all solvency ratios
for Xenon Pharmaceuticals Inc.
Provide D/E Ratio
for Xenon Pharmaceuticals Inc.
Provide D/A Ratio
for Xenon Pharmaceuticals Inc.
Provide Interest Coverage Ratio
for Xenon Pharmaceuticals Inc.
Provide Altman Z-Score Ratio
for Xenon Pharmaceuticals Inc.
Provide Quick Ratio
for Xenon Pharmaceuticals Inc.
Provide Current Ratio
for Xenon Pharmaceuticals Inc.
Provide Cash Ratio
for Xenon Pharmaceuticals Inc.
What is the historical Revenue growth
over the last 5 years for Xenon Pharmaceuticals Inc?
What is the historical Net Income growth
over the last 5 years for Xenon Pharmaceuticals Inc?
What is the current Free Cash Flow
of Xenon Pharmaceuticals Inc?
Discuss the annual earnings per share (EPS)
trend over the past five years for Xenon Pharmaceuticals Inc.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
CA |
X
|
Xenon Pharmaceuticals Inc
F:XP0
|
2.3B EUR | -6.1 | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
6T USD | -194 789.6 |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
336.1B USD | 15.4 |
|
US |
![]() |
Cyclo Therapeutics Inc
NASDAQ:CYTH
|
325.9B USD | -13 213.5 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
164.8B USD | 14.8 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
144.7B USD | 10.5 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
120.7B USD | 26 |
|
US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | -580 |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
129.7B AUD | 19 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
60.9B USD | 12.1 |
|
US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | -66.5 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
CA |
X
|
Xenon Pharmaceuticals Inc
F:XP0
|
Average EV/EBITDA:
16.3
|
N/A | N/A | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
Negative Multiple: -194 789.6 | N/A | N/A |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
15.4
|
13%
|
1.2 |
|
US |
![]() |
Cyclo Therapeutics Inc
NASDAQ:CYTH
|
Negative Multiple: -13 213.5 | N/A | N/A |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
14.8
|
17%
|
0.9 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
10.5
|
6%
|
1.8 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
26
|
17%
|
1.5 |
|
US |
E
|
Epizyme Inc
F:EPE
|
Negative Multiple: -580 | N/A | N/A |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
19
|
11%
|
1.7 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
12.1
|
11%
|
1.1 |
|
US |
S
|
Seagen Inc
F:SGT
|
Negative Multiple: -66.5 | N/A | N/A |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.